ORUKA THERAPEUTICS INC (ORKA) Stock Earnings & Estimates
USA - NASDAQ:ORKA - US6876041087 - Common Stock
28.23 USD
+1.15 (+4.25%)
28.23 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A 313.82% | ||||||||||||
| EBITDA YoY % growth | -9.68M | -11.44M -18.18% | -16.59M -45.02% | -18.68M -12.60% | -8.1M 56.64% | -5.79M 28.52% | -9.76M -68.57% | -19.319M -97.94% | -10.576M 45.26% | -7.281M 31.16% | -88.096M -1,109.94% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.69M | -11.46M -18.27% | -16.61M -44.94% | -18.71M -12.64% | -8.12M 56.60% | -5.81M 28.45% | -9.77M -68.16% | -19.335M -97.90% | -10.596M 45.20% | -7.296M 31.14% | -88.123M -1,107.83% | N/A -29.06% | N/A -20.67% | N/A -16.64% | N/A -81.98% | N/A -30.42% | N/A -27.66% | N/A 34.47% | N/A 255.81% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -120.96 71.85% | -54.36 55.06% | N/A | N/A | N/A | N/A | N/A | N/A 35.25% | N/A -14.05% | N/A -10.03% | N/A 13.72% | N/A -7.74% | N/A -6.02% | N/A 63.00% | N/A -5.94% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.67 -37.60% | -0.67 -68.30% | -0.71 -54.04% | -0.74 -35.14% | -0.70 -3.97% | -0.52 23.33% | -0.56 21.26% | -0.61 17.94% | -0.66 5.27% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -34.947M -15.27% | -36.924M -47.19% | -39.134M -37.66% | -41.786M -40.14% | -38.352M -9.74% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.55 62.33% | -0.59 | 0.04 | 7.26% |
| Q2 2025 Q2Q % growth | -0.46 | -0.50 | 0.04 | 7.96% |
| Q1 2025 Q2Q % growth | -0.40 | -0.52 | 0.12 | 22.50% |
| Q4 2024 Q2Q % growth | -0.49 | -0.70 | 0.21 | 29.55% |
| Q3 2024 Q2Q % growth | -1.46 -1,360.00% | -0.41 | -1.05 | -256.21% |
| Q2 2020 Q2Q % growth | -8.76 35.96% | -31.58 | 22.82 | 72.26% |
| Q1 2020 Q2Q % growth | -9.96 55.38% | -24.97 | 15.01 | 60.11% |
| Q4 2019 Q2Q % growth | -9.24 | -12.12 | 2.88 | 23.75% |
| Q3 2019 Q2Q % growth | -9.12 | -15.91 | 6.79 | 42.68% |
| Q2 2019 Q2Q % growth | -13.68 | -22.77 | 9.09 | 39.91% |
| Q1 2019 Q2Q % growth | -22.32 | -24.24 | 1.92 | 7.90% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.67% | -1.5% | 0% | -1.45% |
| Revenue | N/A | N/A | N/A | N/A |